Reconciliation of 2006 third-quarter/9-month net sales to 2006 third- quarter/9-month comparable net sales:
euro million 2006: Q3
2006 third-quarter net sales 6,901
Impact of changes in Group structure (14)
Impact of exchange rates (156)
2006 third-quarter comparable net sales 6,731
euro million 2006: 9 months
2006 9-month net sales 21,017
Impact of changes in Group structure (44)
Impact of exchange rates (748)
2006 9-month comparable net sales 20,225
Worldwide presence of a product
When we refer to the "worldwide presence" of a product, we mean our consolidated net sales of that product, minus sales of the product to our alliance partners plus non-consolidated sales made through our alliances with Bristol-Myers Squibb on Plavix(R)/Iscover(R) (clopidogrel) and Aprovel(R)/Avapro(R)/Karvea(R) (irbesartan), based on information provided to us by our alliance partner.
Operating income -- current
We define "operating income -- current" as operating income before restructuring, impairment of property, plant and equipment and intangibles, gains/losses on disposals, and litigation.
Adjusted net income
We define "adjusted net income" as accounting net income after minority
interests adjusted to exclude (i) the material impacts of the application
of purchase accounting to acquisitions and (ii) acquisition-related
integration and restructuring costs. We believe that eliminating these
impacts from net income gives investors a better understanding of the
Copyright©2007 PR Newswire.
All rights reserved